nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—ABCC4—Tioguanine—hematologic cancer	0.119	0.209	CbGbCtD
Adefovir Dipivoxil—SLC22A3—Melphalan—hematologic cancer	0.111	0.195	CbGbCtD
Adefovir Dipivoxil—ABCC5—Mercaptopurine—hematologic cancer	0.103	0.181	CbGbCtD
Adefovir Dipivoxil—ABCC5—Cisplatin—hematologic cancer	0.0517	0.0911	CbGbCtD
Adefovir Dipivoxil—ABCC4—Mercaptopurine—hematologic cancer	0.0493	0.0869	CbGbCtD
Adefovir Dipivoxil—SLC22A3—Irinotecan—hematologic cancer	0.0375	0.0661	CbGbCtD
Adefovir Dipivoxil—SLC22A3—Vincristine—hematologic cancer	0.0328	0.0577	CbGbCtD
Adefovir Dipivoxil—SLC22A8—Mercaptopurine—hematologic cancer	0.0308	0.0543	CbGbCtD
Adefovir Dipivoxil—ABCC4—Methotrexate—hematologic cancer	0.0161	0.0284	CbGbCtD
Adefovir Dipivoxil—SLC22A8—Methotrexate—hematologic cancer	0.0101	0.0178	CbGbCtD
Adefovir Dipivoxil—SLC22A6—Methotrexate—hematologic cancer	0.00702	0.0124	CbGbCtD
Adefovir Dipivoxil—NME1-NME2—hematopoietic system—hematologic cancer	0.00645	0.0904	CbGeAlD
Adefovir Dipivoxil—NME1—hematopoietic system—hematologic cancer	0.00375	0.0526	CbGeAlD
Adefovir Dipivoxil—NME2—hematopoietic system—hematologic cancer	0.00353	0.0495	CbGeAlD
Adefovir Dipivoxil—AK2—blood—hematologic cancer	0.00324	0.0454	CbGeAlD
Adefovir Dipivoxil—AK2—bone marrow—hematologic cancer	0.00313	0.0439	CbGeAlD
Adefovir Dipivoxil—AK2—lung—hematologic cancer	0.00284	0.0398	CbGeAlD
Adefovir Dipivoxil—AK4—gonad—hematologic cancer	0.00275	0.0385	CbGeAlD
Adefovir Dipivoxil—AK2—testis—hematologic cancer	0.00268	0.0376	CbGeAlD
Adefovir Dipivoxil—NME1-NME2—lymph node—hematologic cancer	0.00256	0.0359	CbGeAlD
Adefovir Dipivoxil—NME1—bone marrow—hematologic cancer	0.00241	0.0337	CbGeAlD
Adefovir Dipivoxil—NME2—blood—hematologic cancer	0.00234	0.0328	CbGeAlD
Adefovir Dipivoxil—NME1—lung—hematologic cancer	0.00218	0.0305	CbGeAlD
Adefovir Dipivoxil—AK4—lung—hematologic cancer	0.0021	0.0294	CbGeAlD
Adefovir Dipivoxil—NME1—testis—hematologic cancer	0.00206	0.0288	CbGeAlD
Adefovir Dipivoxil—NME2—lung—hematologic cancer	0.00205	0.0288	CbGeAlD
Adefovir Dipivoxil—AK4—testis—hematologic cancer	0.00198	0.0278	CbGeAlD
Adefovir Dipivoxil—AK2—lymph node—hematologic cancer	0.00194	0.0272	CbGeAlD
Adefovir Dipivoxil—NME2—testis—hematologic cancer	0.00194	0.0272	CbGeAlD
Adefovir Dipivoxil—NME1—Ponatinib—Nilotinib—hematologic cancer	0.00179	0.504	CbGdCrCtD
Adefovir Dipivoxil—NME1—lymph node—hematologic cancer	0.00149	0.0209	CbGeAlD
Adefovir Dipivoxil—SLC22A3—hematopoietic system—hematologic cancer	0.00147	0.0206	CbGeAlD
Adefovir Dipivoxil—AK4—lymph node—hematologic cancer	0.00144	0.0201	CbGeAlD
Adefovir Dipivoxil—ABCC4—hematopoietic system—hematologic cancer	0.00142	0.0199	CbGeAlD
Adefovir Dipivoxil—SLC22A8—hematopoietic system—hematologic cancer	0.00141	0.0198	CbGeAlD
Adefovir Dipivoxil—NME2—lymph node—hematologic cancer	0.0014	0.0197	CbGeAlD
Adefovir Dipivoxil—NME1—Ponatinib—Imatinib—hematologic cancer	0.00136	0.382	CbGdCrCtD
Adefovir Dipivoxil—ABCC5—bone marrow—hematologic cancer	0.00132	0.0184	CbGeAlD
Adefovir Dipivoxil—ABCC5—lung—hematologic cancer	0.00119	0.0167	CbGeAlD
Adefovir Dipivoxil—ABCC5—testis—hematologic cancer	0.00113	0.0158	CbGeAlD
Adefovir Dipivoxil—SLC22A3—gonad—hematologic cancer	0.00112	0.0156	CbGeAlD
Adefovir Dipivoxil—ABCC4—blood—hematologic cancer	0.000943	0.0132	CbGeAlD
Adefovir Dipivoxil—SLC22A8—blood—hematologic cancer	0.000935	0.0131	CbGeAlD
Adefovir Dipivoxil—ABCC4—bone marrow—hematologic cancer	0.000912	0.0128	CbGeAlD
Adefovir Dipivoxil—SLC22A3—lung—hematologic cancer	0.000852	0.0119	CbGeAlD
Adefovir Dipivoxil—ABCC4—lung—hematologic cancer	0.000826	0.0116	CbGeAlD
Adefovir Dipivoxil—ABCC5—lymph node—hematologic cancer	0.000815	0.0114	CbGeAlD
Adefovir Dipivoxil—SLC22A3—testis—hematologic cancer	0.000804	0.0113	CbGeAlD
Adefovir Dipivoxil—ABCC4—testis—hematologic cancer	0.00078	0.0109	CbGeAlD
Adefovir Dipivoxil—SLC22A3—lymph node—hematologic cancer	0.000583	0.00817	CbGeAlD
Adefovir Dipivoxil—ABCC4—lymph node—hematologic cancer	0.000565	0.00792	CbGeAlD
Adefovir Dipivoxil—NME1—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000137	0.0386	CbGdCrCtD
Adefovir Dipivoxil—NME1—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000137	0.0386	CbGdCrCtD
Adefovir Dipivoxil—NME1—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000134	0.0377	CbGdCrCtD
Adefovir Dipivoxil—Dermatitis—Thiotepa—hematologic cancer	6.36e-05	0.000267	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Alitretinoin—hematologic cancer	6.36e-05	0.000267	CcSEcCtD
Adefovir Dipivoxil—Headache—Thiotepa—hematologic cancer	6.33e-05	0.000265	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Etoposide—hematologic cancer	6.31e-05	0.000264	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Ifosfamide—hematologic cancer	6.29e-05	0.000264	CcSEcCtD
Adefovir Dipivoxil—Nausea—Vinorelbine—hematologic cancer	6.28e-05	0.000263	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Epirubicin—hematologic cancer	6.27e-05	0.000263	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Etoposide—hematologic cancer	6.26e-05	0.000263	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Cisplatin—hematologic cancer	6.26e-05	0.000263	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Mitoxantrone—hematologic cancer	6.26e-05	0.000262	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Irinotecan—hematologic cancer	6.26e-05	0.000262	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Betamethasone—hematologic cancer	6.23e-05	0.000261	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Dexamethasone—hematologic cancer	6.23e-05	0.000261	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Epirubicin—hematologic cancer	6.22e-05	0.000261	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Thalidomide—hematologic cancer	6.21e-05	0.00026	CcSEcCtD
Adefovir Dipivoxil—Rash—Thalidomide—hematologic cancer	6.16e-05	0.000258	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Thalidomide—hematologic cancer	6.15e-05	0.000258	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Vincristine—hematologic cancer	6.13e-05	0.000257	CcSEcCtD
Adefovir Dipivoxil—Headache—Thalidomide—hematologic cancer	6.12e-05	0.000257	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Methotrexate—hematologic cancer	6.12e-05	0.000256	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Gemcitabine—hematologic cancer	6.1e-05	0.000256	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Epirubicin—hematologic cancer	6.08e-05	0.000255	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Methotrexate—hematologic cancer	6.07e-05	0.000255	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Methotrexate—hematologic cancer	6.04e-05	0.000253	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Epirubicin—hematologic cancer	6.03e-05	0.000253	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Gemcitabine—hematologic cancer	6.01e-05	0.000252	CcSEcCtD
Adefovir Dipivoxil—Nausea—Thiotepa—hematologic cancer	6e-05	0.000252	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Methotrexate—hematologic cancer	6e-05	0.000251	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	6e-05	0.000251	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Doxorubicin—hematologic cancer	5.99e-05	0.000251	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Epirubicin—hematologic cancer	5.98e-05	0.000251	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Mitoxantrone—hematologic cancer	5.97e-05	0.00025	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Irinotecan—hematologic cancer	5.97e-05	0.00025	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Carmustine—hematologic cancer	5.97e-05	0.00025	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Etoposide—hematologic cancer	5.93e-05	0.000249	CcSEcCtD
Adefovir Dipivoxil—Rash—Carmustine—hematologic cancer	5.92e-05	0.000248	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Carmustine—hematologic cancer	5.91e-05	0.000248	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Alitretinoin—hematologic cancer	5.91e-05	0.000248	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Prednisone—hematologic cancer	5.89e-05	0.000247	CcSEcCtD
Adefovir Dipivoxil—Headache—Carmustine—hematologic cancer	5.88e-05	0.000246	CcSEcCtD
Adefovir Dipivoxil—Rash—Alitretinoin—hematologic cancer	5.86e-05	0.000246	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Dexamethasone—hematologic cancer	5.86e-05	0.000246	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Betamethasone—hematologic cancer	5.86e-05	0.000246	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Alitretinoin—hematologic cancer	5.86e-05	0.000246	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Dexamethasone—hematologic cancer	5.85e-05	0.000245	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Betamethasone—hematologic cancer	5.85e-05	0.000245	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Ifosfamide—hematologic cancer	5.84e-05	0.000245	CcSEcCtD
Adefovir Dipivoxil—Headache—Alitretinoin—hematologic cancer	5.82e-05	0.000244	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Gemcitabine—hematologic cancer	5.81e-05	0.000244	CcSEcCtD
Adefovir Dipivoxil—Nausea—Thalidomide—hematologic cancer	5.8e-05	0.000243	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Doxorubicin—hematologic cancer	5.8e-05	0.000243	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Triamcinolone—hematologic cancer	5.79e-05	0.000243	CcSEcCtD
Adefovir Dipivoxil—Rash—Ifosfamide—hematologic cancer	5.79e-05	0.000243	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Ifosfamide—hematologic cancer	5.79e-05	0.000243	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Doxorubicin—hematologic cancer	5.75e-05	0.000241	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Etoposide—hematologic cancer	5.74e-05	0.00024	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Etoposide—hematologic cancer	5.74e-05	0.00024	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Epirubicin—hematologic cancer	5.73e-05	0.00024	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Vincristine—hematologic cancer	5.7e-05	0.000239	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Betamethasone—hematologic cancer	5.69e-05	0.000239	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Dexamethasone—hematologic cancer	5.69e-05	0.000239	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Cisplatin—hematologic cancer	5.68e-05	0.000238	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Epirubicin—hematologic cancer	5.68e-05	0.000238	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Epirubicin—hematologic cancer	5.65e-05	0.000237	CcSEcCtD
Adefovir Dipivoxil—Rash—Vincristine—hematologic cancer	5.65e-05	0.000237	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Vincristine—hematologic cancer	5.64e-05	0.000237	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Doxorubicin—hematologic cancer	5.63e-05	0.000236	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Epirubicin—hematologic cancer	5.63e-05	0.000236	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Epirubicin—hematologic cancer	5.61e-05	0.000235	CcSEcCtD
Adefovir Dipivoxil—Headache—Vincristine—hematologic cancer	5.61e-05	0.000235	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Doxorubicin—hematologic cancer	5.58e-05	0.000234	CcSEcCtD
Adefovir Dipivoxil—Nausea—Carmustine—hematologic cancer	5.57e-05	0.000234	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Mitoxantrone—hematologic cancer	5.55e-05	0.000233	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Irinotecan—hematologic cancer	5.55e-05	0.000233	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Doxorubicin—hematologic cancer	5.54e-05	0.000232	CcSEcCtD
Adefovir Dipivoxil—Nausea—Alitretinoin—hematologic cancer	5.52e-05	0.000232	CcSEcCtD
Adefovir Dipivoxil—Rash—Mitoxantrone—hematologic cancer	5.5e-05	0.000231	CcSEcCtD
Adefovir Dipivoxil—Rash—Irinotecan—hematologic cancer	5.5e-05	0.000231	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Irinotecan—hematologic cancer	5.5e-05	0.00023	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Mitoxantrone—hematologic cancer	5.5e-05	0.00023	CcSEcCtD
Adefovir Dipivoxil—Headache—Irinotecan—hematologic cancer	5.47e-05	0.000229	CcSEcCtD
Adefovir Dipivoxil—Headache—Mitoxantrone—hematologic cancer	5.47e-05	0.000229	CcSEcCtD
Adefovir Dipivoxil—Nausea—Ifosfamide—hematologic cancer	5.46e-05	0.000229	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Betamethasone—hematologic cancer	5.44e-05	0.000228	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	5.44e-05	0.000228	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Prednisone—hematologic cancer	5.43e-05	0.000227	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Cisplatin—hematologic cancer	5.42e-05	0.000227	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Gemcitabine—hematologic cancer	5.4e-05	0.000227	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	5.39e-05	0.000226	CcSEcCtD
Adefovir Dipivoxil—Rash—Gemcitabine—hematologic cancer	5.36e-05	0.000225	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Gemcitabine—hematologic cancer	5.35e-05	0.000224	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Methotrexate—hematologic cancer	5.33e-05	0.000223	CcSEcCtD
Adefovir Dipivoxil—Headache—Gemcitabine—hematologic cancer	5.32e-05	0.000223	CcSEcCtD
Adefovir Dipivoxil—Nausea—Vincristine—hematologic cancer	5.32e-05	0.000223	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Doxorubicin—hematologic cancer	5.3e-05	0.000222	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Doxorubicin—hematologic cancer	5.26e-05	0.00022	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Dexamethasone—hematologic cancer	5.26e-05	0.00022	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Betamethasone—hematologic cancer	5.26e-05	0.00022	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Doxorubicin—hematologic cancer	5.23e-05	0.000219	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Etoposide—hematologic cancer	5.21e-05	0.000218	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Doxorubicin—hematologic cancer	5.21e-05	0.000218	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Triamcinolone—hematologic cancer	5.2e-05	0.000218	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Doxorubicin—hematologic cancer	5.19e-05	0.000218	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Dexamethasone—hematologic cancer	5.19e-05	0.000218	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Betamethasone—hematologic cancer	5.19e-05	0.000218	CcSEcCtD
Adefovir Dipivoxil—Nausea—Irinotecan—hematologic cancer	5.18e-05	0.000217	CcSEcCtD
Adefovir Dipivoxil—Nausea—Mitoxantrone—hematologic cancer	5.18e-05	0.000217	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.16e-05	0.000216	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.16e-05	0.000216	CcSEcCtD
Adefovir Dipivoxil—Back pain—Methotrexate—hematologic cancer	5.15e-05	0.000216	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Etoposide—hematologic cancer	5.13e-05	0.000215	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Prednisone—hematologic cancer	5.1e-05	0.000214	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Prednisone—hematologic cancer	5.05e-05	0.000212	CcSEcCtD
Adefovir Dipivoxil—Nausea—Gemcitabine—hematologic cancer	5.05e-05	0.000212	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Cisplatin—hematologic cancer	5.04e-05	0.000211	CcSEcCtD
Adefovir Dipivoxil—Rash—Cisplatin—hematologic cancer	4.99e-05	0.000209	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Cisplatin—hematologic cancer	4.99e-05	0.000209	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Epirubicin—hematologic cancer	4.98e-05	0.000209	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Etoposide—hematologic cancer	4.96e-05	0.000208	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Prednisone—hematologic cancer	4.96e-05	0.000208	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Methotrexate—hematologic cancer	4.92e-05	0.000206	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Epirubicin—hematologic cancer	4.91e-05	0.000206	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Betamethasone—hematologic cancer	4.88e-05	0.000205	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.88e-05	0.000205	CcSEcCtD
Adefovir Dipivoxil—Back pain—Epirubicin—hematologic cancer	4.82e-05	0.000202	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.74e-05	0.000199	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Triamcinolone—hematologic cancer	4.72e-05	0.000198	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Dexamethasone—hematologic cancer	4.72e-05	0.000198	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Betamethasone—hematologic cancer	4.72e-05	0.000198	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Dexamethasone—hematologic cancer	4.72e-05	0.000198	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Betamethasone—hematologic cancer	4.72e-05	0.000198	CcSEcCtD
Adefovir Dipivoxil—Nausea—Cisplatin—hematologic cancer	4.7e-05	0.000197	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Triamcinolone—hematologic cancer	4.66e-05	0.000195	CcSEcCtD
Adefovir Dipivoxil—Cough—Methotrexate—hematologic cancer	4.65e-05	0.000195	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Etoposide—hematologic cancer	4.61e-05	0.000193	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Doxorubicin—hematologic cancer	4.61e-05	0.000193	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Epirubicin—hematologic cancer	4.61e-05	0.000193	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Prednisone—hematologic cancer	4.58e-05	0.000192	CcSEcCtD
Adefovir Dipivoxil—Rash—Etoposide—hematologic cancer	4.58e-05	0.000192	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Etoposide—hematologic cancer	4.57e-05	0.000192	CcSEcCtD
Adefovir Dipivoxil—Headache—Etoposide—hematologic cancer	4.55e-05	0.000191	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Doxorubicin—hematologic cancer	4.54e-05	0.000191	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Methotrexate—hematologic cancer	4.53e-05	0.00019	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Methotrexate—hematologic cancer	4.53e-05	0.00019	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Prednisone—hematologic cancer	4.52e-05	0.00019	CcSEcCtD
Adefovir Dipivoxil—Rash—Prednisolone—hematologic cancer	4.51e-05	0.000189	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Prednisolone—hematologic cancer	4.51e-05	0.000189	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.5e-05	0.000189	CcSEcCtD
Adefovir Dipivoxil—Headache—Prednisolone—hematologic cancer	4.48e-05	0.000188	CcSEcCtD
Adefovir Dipivoxil—Back pain—Doxorubicin—hematologic cancer	4.46e-05	0.000187	CcSEcCtD
Adefovir Dipivoxil—Cough—Epirubicin—hematologic cancer	4.35e-05	0.000182	CcSEcCtD
Adefovir Dipivoxil—Nausea—Etoposide—hematologic cancer	4.31e-05	0.000181	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Betamethasone—hematologic cancer	4.28e-05	0.00018	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Dexamethasone—hematologic cancer	4.28e-05	0.00018	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Methotrexate—hematologic cancer	4.26e-05	0.000179	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Doxorubicin—hematologic cancer	4.26e-05	0.000179	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Methotrexate—hematologic cancer	4.26e-05	0.000178	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Prednisone—hematologic cancer	4.25e-05	0.000178	CcSEcCtD
Adefovir Dipivoxil—Nausea—Prednisolone—hematologic cancer	4.25e-05	0.000178	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Epirubicin—hematologic cancer	4.24e-05	0.000178	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Epirubicin—hematologic cancer	4.24e-05	0.000178	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Dexamethasone—hematologic cancer	4.23e-05	0.000177	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Betamethasone—hematologic cancer	4.23e-05	0.000177	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Methotrexate—hematologic cancer	4.22e-05	0.000177	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.21e-05	0.000177	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Triamcinolone—hematologic cancer	4.18e-05	0.000175	CcSEcCtD
Adefovir Dipivoxil—Rash—Triamcinolone—hematologic cancer	4.15e-05	0.000174	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Triamcinolone—hematologic cancer	4.15e-05	0.000174	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Methotrexate—hematologic cancer	4.14e-05	0.000174	CcSEcCtD
Adefovir Dipivoxil—Headache—Triamcinolone—hematologic cancer	4.12e-05	0.000173	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Prednisone—hematologic cancer	4.11e-05	0.000172	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Prednisone—hematologic cancer	4.11e-05	0.000172	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Betamethasone—hematologic cancer	4.09e-05	0.000171	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Dexamethasone—hematologic cancer	4.09e-05	0.000171	CcSEcCtD
Adefovir Dipivoxil—Cough—Doxorubicin—hematologic cancer	4.02e-05	0.000169	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Epirubicin—hematologic cancer	3.99e-05	0.000167	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Epirubicin—hematologic cancer	3.98e-05	0.000167	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.96e-05	0.000166	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Epirubicin—hematologic cancer	3.95e-05	0.000166	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Doxorubicin—hematologic cancer	3.93e-05	0.000165	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Doxorubicin—hematologic cancer	3.93e-05	0.000165	CcSEcCtD
Adefovir Dipivoxil—Nausea—Triamcinolone—hematologic cancer	3.91e-05	0.000164	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.9e-05	0.000163	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Epirubicin—hematologic cancer	3.88e-05	0.000163	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Methotrexate—hematologic cancer	3.83e-05	0.00016	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Dexamethasone—hematologic cancer	3.8e-05	0.000159	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Betamethasone—hematologic cancer	3.8e-05	0.000159	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Methotrexate—hematologic cancer	3.78e-05	0.000158	CcSEcCtD
Adefovir Dipivoxil—Rash—Dexamethasone—hematologic cancer	3.77e-05	0.000158	CcSEcCtD
Adefovir Dipivoxil—Rash—Betamethasone—hematologic cancer	3.77e-05	0.000158	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Betamethasone—hematologic cancer	3.76e-05	0.000158	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Dexamethasone—hematologic cancer	3.76e-05	0.000158	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.75e-05	0.000157	CcSEcCtD
Adefovir Dipivoxil—Headache—Dexamethasone—hematologic cancer	3.74e-05	0.000157	CcSEcCtD
Adefovir Dipivoxil—Headache—Betamethasone—hematologic cancer	3.74e-05	0.000157	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Prednisone—hematologic cancer	3.73e-05	0.000156	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.71e-05	0.000155	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Doxorubicin—hematologic cancer	3.69e-05	0.000155	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Doxorubicin—hematologic cancer	3.68e-05	0.000154	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Prednisone—hematologic cancer	3.68e-05	0.000154	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Doxorubicin—hematologic cancer	3.66e-05	0.000153	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Doxorubicin—hematologic cancer	3.59e-05	0.00015	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Epirubicin—hematologic cancer	3.58e-05	0.00015	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Prednisone—hematologic cancer	3.56e-05	0.000149	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Methotrexate—hematologic cancer	3.55e-05	0.000149	CcSEcCtD
Adefovir Dipivoxil—Nausea—Betamethasone—hematologic cancer	3.55e-05	0.000149	CcSEcCtD
Adefovir Dipivoxil—Nausea—Dexamethasone—hematologic cancer	3.55e-05	0.000149	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Epirubicin—hematologic cancer	3.54e-05	0.000148	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.51e-05	0.000147	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Methotrexate—hematologic cancer	3.44e-05	0.000144	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Methotrexate—hematologic cancer	3.44e-05	0.000144	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.43e-05	0.000144	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Epirubicin—hematologic cancer	3.33e-05	0.000139	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Doxorubicin—hematologic cancer	3.31e-05	0.000139	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Prednisone—hematologic cancer	3.31e-05	0.000139	CcSEcCtD
Adefovir Dipivoxil—Rash—Prednisone—hematologic cancer	3.28e-05	0.000137	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Prednisone—hematologic cancer	3.28e-05	0.000137	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Doxorubicin—hematologic cancer	3.27e-05	0.000137	CcSEcCtD
Adefovir Dipivoxil—Headache—Prednisone—hematologic cancer	3.26e-05	0.000137	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.25e-05	0.000136	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Epirubicin—hematologic cancer	3.22e-05	0.000135	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Epirubicin—hematologic cancer	3.22e-05	0.000135	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Methotrexate—hematologic cancer	3.12e-05	0.000131	CcSEcCtD
Adefovir Dipivoxil—Nausea—Prednisone—hematologic cancer	3.09e-05	0.00013	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.08e-05	0.000129	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Methotrexate—hematologic cancer	3.08e-05	0.000129	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Doxorubicin—hematologic cancer	2.98e-05	0.000125	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Doxorubicin—hematologic cancer	2.98e-05	0.000125	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Methotrexate—hematologic cancer	2.97e-05	0.000125	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Epirubicin—hematologic cancer	2.92e-05	0.000122	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Epirubicin—hematologic cancer	2.88e-05	0.000121	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Epirubicin—hematologic cancer	2.78e-05	0.000117	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Methotrexate—hematologic cancer	2.76e-05	0.000116	CcSEcCtD
Adefovir Dipivoxil—Rash—Methotrexate—hematologic cancer	2.74e-05	0.000115	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Methotrexate—hematologic cancer	2.74e-05	0.000115	CcSEcCtD
Adefovir Dipivoxil—Headache—Methotrexate—hematologic cancer	2.72e-05	0.000114	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Metabolism—FHL2—hematologic cancer	2.72e-05	0.000228	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—IDH1—hematologic cancer	2.71e-05	0.000227	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3R1—hematologic cancer	2.7e-05	0.000227	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Doxorubicin—hematologic cancer	2.7e-05	0.000113	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Disease—CST3—hematologic cancer	2.7e-05	0.000226	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ADCY7—hematologic cancer	2.68e-05	0.000225	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTO1—hematologic cancer	2.68e-05	0.000225	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ABCC3—hematologic cancer	2.68e-05	0.000225	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—TXN—hematologic cancer	2.68e-05	0.000225	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GSTP1—hematologic cancer	2.66e-05	0.000223	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—AGRN—hematologic cancer	2.66e-05	0.000223	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Doxorubicin—hematologic cancer	2.66e-05	0.000112	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Disease—NUP214—hematologic cancer	2.66e-05	0.000223	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IFNA2—hematologic cancer	2.66e-05	0.000223	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CB—hematologic cancer	2.65e-05	0.000222	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—JAK2—hematologic cancer	2.63e-05	0.00022	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SPHK1—hematologic cancer	2.62e-05	0.00022	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—MYC—hematologic cancer	2.61e-05	0.000219	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MTR—hematologic cancer	2.61e-05	0.000219	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—XIAP—hematologic cancer	2.61e-05	0.000219	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—ALB—hematologic cancer	2.59e-05	0.000217	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Epirubicin—hematologic cancer	2.59e-05	0.000108	CcSEcCtD
Adefovir Dipivoxil—Nausea—Methotrexate—hematologic cancer	2.58e-05	0.000108	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Doxorubicin—hematologic cancer	2.58e-05	0.000108	CcSEcCtD
Adefovir Dipivoxil—Rash—Epirubicin—hematologic cancer	2.56e-05	0.000108	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Epirubicin—hematologic cancer	2.56e-05	0.000107	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Disease—ENO2—hematologic cancer	2.55e-05	0.000214	CbGpPWpGaD
Adefovir Dipivoxil—Headache—Epirubicin—hematologic cancer	2.55e-05	0.000107	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Disease—SMARCA4—hematologic cancer	2.54e-05	0.000213	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HMMR—hematologic cancer	2.52e-05	0.000212	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—IDH2—hematologic cancer	2.52e-05	0.000212	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ABCB1—hematologic cancer	2.52e-05	0.000212	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.52e-05	0.000211	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—UGT1A1—hematologic cancer	2.52e-05	0.000211	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—TFRC—hematologic cancer	2.51e-05	0.00021	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—GRB2—hematologic cancer	2.5e-05	0.00021	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PDGFA—hematologic cancer	2.49e-05	0.000209	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—hematologic cancer	2.49e-05	0.000209	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—TGFB1—hematologic cancer	2.49e-05	0.000209	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—NCOR1—hematologic cancer	2.45e-05	0.000205	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SLC22A1—hematologic cancer	2.45e-05	0.000205	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GSTM1—hematologic cancer	2.45e-05	0.000205	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CRABP1—hematologic cancer	2.45e-05	0.000205	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SDC1—hematologic cancer	2.42e-05	0.000203	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Epirubicin—hematologic cancer	2.42e-05	0.000101	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.42e-05	0.000203	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—ABL1—hematologic cancer	2.4e-05	0.000202	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CG—hematologic cancer	2.4e-05	0.000201	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Doxorubicin—hematologic cancer	2.39e-05	0.0001	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Metabolism—ALOX5—hematologic cancer	2.39e-05	0.0002	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ARNTL—hematologic cancer	2.37e-05	0.000199	CbGpPWpGaD
Adefovir Dipivoxil—Rash—Doxorubicin—hematologic cancer	2.37e-05	9.95e-05	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Doxorubicin—hematologic cancer	2.37e-05	9.94e-05	CcSEcCtD
Adefovir Dipivoxil—Headache—Doxorubicin—hematologic cancer	2.36e-05	9.88e-05	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Disease—LCK—hematologic cancer	2.35e-05	0.000197	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.33e-05	0.000196	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NUP98—hematologic cancer	2.31e-05	0.000194	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CA9—hematologic cancer	2.31e-05	0.000194	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ACP5—hematologic cancer	2.31e-05	0.000194	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—H3F3A—hematologic cancer	2.3e-05	0.000193	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PTEN—hematologic cancer	2.29e-05	0.000192	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—IL2—hematologic cancer	2.29e-05	0.000192	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NCOR2—hematologic cancer	2.28e-05	0.000191	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—HGF—hematologic cancer	2.26e-05	0.00019	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ADCY7—hematologic cancer	2.24e-05	0.000188	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NCOA3—hematologic cancer	2.24e-05	0.000188	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Doxorubicin—hematologic cancer	2.24e-05	9.37e-05	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Disease—PRKCZ—hematologic cancer	2.24e-05	0.000187	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—CSF2—hematologic cancer	2.23e-05	0.000187	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NUP214—hematologic cancer	2.23e-05	0.000187	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CREBBP—hematologic cancer	2.22e-05	0.000187	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CALR—hematologic cancer	2.2e-05	0.000184	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—EP300—hematologic cancer	2.18e-05	0.000183	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—MTR—hematologic cancer	2.18e-05	0.000183	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ABCG2—hematologic cancer	2.18e-05	0.000183	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—IDH1—hematologic cancer	2.17e-05	0.000182	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—MTHFR—hematologic cancer	2.16e-05	0.000181	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—ALB—hematologic cancer	2.16e-05	0.000181	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PARP1—hematologic cancer	2.16e-05	0.000181	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—JAK1—hematologic cancer	2.16e-05	0.000181	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PRKCG—hematologic cancer	2.16e-05	0.000181	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTO1—hematologic cancer	2.15e-05	0.00018	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ABCC3—hematologic cancer	2.15e-05	0.00018	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—TXN—hematologic cancer	2.15e-05	0.00018	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ENO2—hematologic cancer	2.14e-05	0.000179	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FBXW7—hematologic cancer	2.12e-05	0.000178	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CD—hematologic cancer	2.11e-05	0.000177	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.1e-05	0.000176	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.1e-05	0.000176	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SPHK1—hematologic cancer	2.1e-05	0.000176	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CXCR4—hematologic cancer	2.08e-05	0.000175	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HDAC2—hematologic cancer	2.08e-05	0.000175	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ALB—hematologic cancer	2.08e-05	0.000175	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTT1—hematologic cancer	2.08e-05	0.000174	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CD44—hematologic cancer	2.06e-05	0.000173	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CBL—hematologic cancer	2.03e-05	0.00017	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SDC1—hematologic cancer	2.03e-05	0.00017	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—UGT1A1—hematologic cancer	2.02e-05	0.000169	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.02e-05	0.000169	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IL2RA—hematologic cancer	2.01e-05	0.000169	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—SRC—hematologic cancer	2e-05	0.000168	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3R1—hematologic cancer	1.99e-05	0.000167	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SLC22A1—hematologic cancer	1.96e-05	0.000165	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CRABP1—hematologic cancer	1.96e-05	0.000165	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	1.95e-05	0.000163	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PDGFB—hematologic cancer	1.94e-05	0.000163	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.94e-05	0.000163	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HSP90AA1—hematologic cancer	1.94e-05	0.000162	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ALOX5—hematologic cancer	1.91e-05	0.00016	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—CDK2—hematologic cancer	1.89e-05	0.000158	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—STAT1—hematologic cancer	1.87e-05	0.000157	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NUP98—hematologic cancer	1.85e-05	0.000155	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	1.84e-05	0.000154	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CB—hematologic cancer	1.84e-05	0.000154	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—ALB—hematologic cancer	1.82e-05	0.000153	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CG—hematologic cancer	1.82e-05	0.000152	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—MAPK14—hematologic cancer	1.81e-05	0.000152	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ADCY7—hematologic cancer	1.8e-05	0.000151	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NCOA3—hematologic cancer	1.8e-05	0.000151	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	1.79e-05	0.00015	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NUP214—hematologic cancer	1.79e-05	0.00015	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.75e-05	0.000147	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—FN1—hematologic cancer	1.75e-05	0.000147	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ABCG2—hematologic cancer	1.75e-05	0.000147	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—MTR—hematologic cancer	1.75e-05	0.000147	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—GRB2—hematologic cancer	1.75e-05	0.000147	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PDGFA—hematologic cancer	1.74e-05	0.000146	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CD44—hematologic cancer	1.72e-05	0.000145	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NQO1—hematologic cancer	1.72e-05	0.000145	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—KITLG—hematologic cancer	1.72e-05	0.000144	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ENO2—hematologic cancer	1.72e-05	0.000144	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CREBBP—hematologic cancer	1.69e-05	0.000141	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—STAT5A—hematologic cancer	1.68e-05	0.000141	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CG—hematologic cancer	1.68e-05	0.000141	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTT1—hematologic cancer	1.66e-05	0.00014	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CDKN2B—hematologic cancer	1.66e-05	0.00014	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PTPN11—hematologic cancer	1.65e-05	0.000138	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYCS—hematologic cancer	1.63e-05	0.000137	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SDC1—hematologic cancer	1.63e-05	0.000136	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—HSP90AA1—hematologic cancer	1.62e-05	0.000136	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CA—hematologic cancer	1.62e-05	0.000136	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CD86—hematologic cancer	1.61e-05	0.000135	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CD—hematologic cancer	1.6e-05	0.000134	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTEN—hematologic cancer	1.59e-05	0.000133	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HES1—hematologic cancer	1.59e-05	0.000133	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NCOR1—hematologic cancer	1.58e-05	0.000132	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ALB—hematologic cancer	1.58e-05	0.000132	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FGF1—hematologic cancer	1.56e-05	0.000131	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.56e-05	0.000131	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—CREBBP—hematologic cancer	1.56e-05	0.000131	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FOXO1—hematologic cancer	1.54e-05	0.000129	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PDGFRB—hematologic cancer	1.54e-05	0.000129	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	1.52e-05	0.000128	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—EP300—hematologic cancer	1.51e-05	0.000127	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PDGFRA—hematologic cancer	1.51e-05	0.000127	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3R1—hematologic cancer	1.51e-05	0.000127	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—JAK1—hematologic cancer	1.51e-05	0.000126	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PRKCG—hematologic cancer	1.51e-05	0.000126	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CD—hematologic cancer	1.48e-05	0.000124	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ALB—hematologic cancer	1.46e-05	0.000122	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—ALB—hematologic cancer	1.46e-05	0.000122	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTP1—hematologic cancer	1.44e-05	0.000121	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.4e-05	0.000118	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MTHFR—hematologic cancer	1.39e-05	0.000117	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3R1—hematologic cancer	1.39e-05	0.000117	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CB—hematologic cancer	1.39e-05	0.000117	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TERT—hematologic cancer	1.39e-05	0.000117	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HLA-A—hematologic cancer	1.39e-05	0.000117	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CD44—hematologic cancer	1.38e-05	0.000116	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NQO1—hematologic cancer	1.38e-05	0.000116	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ABCB1—hematologic cancer	1.36e-05	0.000114	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PDGFB—hematologic cancer	1.36e-05	0.000114	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—JAK2—hematologic cancer	1.35e-05	0.000114	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.35e-05	0.000113	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TSC2—hematologic cancer	1.33e-05	0.000111	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NCOR1—hematologic cancer	1.32e-05	0.000111	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTM1—hematologic cancer	1.32e-05	0.000111	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—AKT1—hematologic cancer	1.32e-05	0.000111	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ALB—hematologic cancer	1.31e-05	0.00011	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYCS—hematologic cancer	1.31e-05	0.00011	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HSP90AA1—hematologic cancer	1.3e-05	0.000109	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CB—hematologic cancer	1.29e-05	0.000108	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FGFR3—hematologic cancer	1.28e-05	0.000107	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ALB—hematologic cancer	1.26e-05	0.000106	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	1.24e-05	0.000104	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—BAD—hematologic cancer	1.21e-05	0.000102	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTEN—hematologic cancer	1.2e-05	0.000101	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NOTCH1—hematologic cancer	1.2e-05	0.000101	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IL2—hematologic cancer	1.18e-05	9.91e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CD80—hematologic cancer	1.17e-05	9.85e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.17e-05	9.83e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—KIT—hematologic cancer	1.17e-05	9.83e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—MTHFR—hematologic cancer	1.17e-05	9.8e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTP1—hematologic cancer	1.15e-05	9.68e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTPN11—hematologic cancer	1.15e-05	9.66e-05	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—EP300—hematologic cancer	1.15e-05	9.63e-05	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CA—hematologic cancer	1.12e-05	9.4e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CREB1—hematologic cancer	1.12e-05	9.36e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—BRAF—hematologic cancer	1.1e-05	9.24e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ALB—hematologic cancer	1.1e-05	9.2e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ABCB1—hematologic cancer	1.09e-05	9.16e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IL6R—hematologic cancer	1.09e-05	9.13e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CREBBP—hematologic cancer	1.09e-05	9.11e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTM1—hematologic cancer	1.06e-05	8.89e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NCOR1—hematologic cancer	1.06e-05	8.89e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—EP300—hematologic cancer	1.06e-05	8.89e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MAP2K1—hematologic cancer	1.04e-05	8.7e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—SRC—hematologic cancer	1.03e-05	8.64e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CD—hematologic cancer	1.03e-05	8.64e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—VEGFA—hematologic cancer	1e-05	8.42e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—NRAS—hematologic cancer	9.91e-06	8.31e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FGF2—hematologic cancer	9.86e-06	8.27e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CG—hematologic cancer	9.81e-06	8.23e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3R1—hematologic cancer	9.73e-06	8.16e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—MAPK3—hematologic cancer	9.49e-06	7.96e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—JAK2—hematologic cancer	9.46e-06	7.93e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—MTHFR—hematologic cancer	9.37e-06	7.86e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MDM2—hematologic cancer	9.23e-06	7.74e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TGFB1—hematologic cancer	9.21e-06	7.73e-05	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—AKT1—hematologic cancer	9.15e-06	7.68e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CREBBP—hematologic cancer	9.1e-06	7.63e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MTOR—hematologic cancer	8.98e-06	7.53e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CB—hematologic cancer	8.98e-06	7.53e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CD4—hematologic cancer	8.96e-06	7.52e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CD—hematologic cancer	8.63e-06	7.24e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—KRAS—hematologic cancer	8.53e-06	7.16e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ALB—hematologic cancer	8.52e-06	7.15e-05	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CA—hematologic cancer	8.49e-06	7.12e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CDKN1B—hematologic cancer	8.43e-06	7.07e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3R1—hematologic cancer	8.15e-06	6.83e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CG—hematologic cancer	7.87e-06	6.6e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CA—hematologic cancer	7.84e-06	6.57e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CDKN1A—hematologic cancer	7.78e-06	6.52e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTEN—hematologic cancer	7.76e-06	6.51e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TP53—hematologic cancer	7.58e-06	6.36e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CB—hematologic cancer	7.52e-06	6.31e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—EP300—hematologic cancer	7.4e-06	6.21e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CREBBP—hematologic cancer	7.3e-06	6.12e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—HRAS—hematologic cancer	7.25e-06	6.08e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SRC—hematologic cancer	7.2e-06	6.04e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—STAT3—hematologic cancer	6.94e-06	5.82e-05	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—AKT1—hematologic cancer	6.94e-06	5.82e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NRAS—hematologic cancer	6.92e-06	5.81e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CD—hematologic cancer	6.92e-06	5.81e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ALB—hematologic cancer	6.83e-06	5.73e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MAPK3—hematologic cancer	6.63e-06	5.56e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3R1—hematologic cancer	6.53e-06	5.48e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTEN—hematologic cancer	6.5e-06	5.45e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MYC—hematologic cancer	6.45e-06	5.41e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TGFB1—hematologic cancer	6.43e-06	5.4e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—AKT1—hematologic cancer	6.4e-06	5.37e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—EP300—hematologic cancer	6.2e-06	5.2e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CB—hematologic cancer	6.03e-06	5.06e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—KRAS—hematologic cancer	5.96e-06	5e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CA—hematologic cancer	5.47e-06	4.59e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTEN—hematologic cancer	5.21e-06	4.37e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HRAS—hematologic cancer	5.06e-06	4.25e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—EP300—hematologic cancer	4.97e-06	4.17e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IL6—hematologic cancer	4.85e-06	4.07e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CA—hematologic cancer	4.58e-06	3.85e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—AKT1—hematologic cancer	4.47e-06	3.75e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—AKT1—hematologic cancer	3.75e-06	3.14e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CA—hematologic cancer	3.68e-06	3.08e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—AKT1—hematologic cancer	3e-06	2.52e-05	CbGpPWpGaD
